Another recent report utilizing Mass Cytometry, revealed the selective targeting of glioma stem cells (characterized as CD98+ cells coexpressing stem cell markers, including Oct3/4, Nestin, SOX2, Musashi-1, PDGFRα, Notch2, Nanog, STAT3 and C-myc) by P-boronophenylalanine (BPA), a chemical compound used in Boron neutron capture therapy [106]. This evidence concerns the gene NES and glioma.